CN Stock MarketDetailed Quotes

603193 Runben Biotechnology

Watchlist
  • 17.42
  • -0.17-0.97%
Market Closed Sep 9 15:00 CST
7.05BMarket Cap24.60P/E (TTM)

Runben Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Assets
Current assets
Money funds
-36.75%259.18M
--104.74M
-33.78%243.83M
--458.6M
60.55%409.79M
78.58%368.21M
--255.25M
421.63%206.19M
27.02%39.53M
--31.12M
Transactional financial assets
61.76%134.6M
--27.64M
130.64%19M
--93.4M
-13.49%83.21M
-85.35%8.24M
--96.19M
33.35%56.24M
883.39%42.17M
--4.29M
Notes receivable and accounts receivable
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
-15.59%2.34M
-16.65%2.78M
--3.33M
-Accounts receivable
563.93%39.58M
--12.36M
303.46%4.82M
--8.44M
-19.43%5.96M
-49.03%1.19M
--7.4M
-15.59%2.34M
-16.65%2.78M
--3.33M
Other receivables (including interest and dividends)
75.46%3.87M
--2.46M
-61.30%2.3M
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
-0.82%1.39M
16.52%1.4M
--1.2M
-Dividend receivable
----
----
----
--0
----
----
----
----
----
----
-Accrued interest receivable
----
----
----
--0
----
----
----
----
----
----
-Other receivable
75.46%3.87M
----
-61.30%2.3M
--3.63M
28.15%2.21M
326.97%5.94M
--1.72M
-0.82%1.39M
16.52%1.4M
--1.2M
Advance payment
-23.29%9.37M
--15.93M
8.61%8.31M
--11.34M
6.69%12.22M
-32.80%7.65M
--11.45M
250.20%11.39M
27.25%3.25M
--2.56M
Inventories
23.68%166.25M
--141.06M
-9.54%92.91M
--101.02M
20.47%134.42M
80.52%102.71M
--111.58M
25.82%56.9M
52.90%45.22M
--29.58M
Other current assets
14,180.24%1.3B
--1.45B
8,258.92%1.35B
--1.46M
15,178.26%9.1M
62.39%16.09M
--59.58K
32.78%9.91M
332.19%7.46M
--1.73M
Total current assets
191.16%1.91B
--1.76B
236.51%1.72B
--677.88M
35.82%656.91M
48.12%510.04M
--483.64M
142.82%344.36M
92.16%141.82M
--73.8M
Non Current assets
Fixed assets
-4.23%249.57M
----
-3.55%254.86M
----
31.04%260.6M
38.76%264.24M
--198.87M
283.00%190.43M
-8.27%49.72M
--54.2M
Fixed assets liquidation
----
----
----
----
----
----
----
----
--1.67K
----
Constru in process
145.88%7.94M
----
-68.36%1.82M
----
-95.07%3.23M
-19.57%5.76M
--65.48M
-87.85%7.17M
349.03%59.01M
--13.14M
Productive biological assets
----
----
----
--0
----
----
----
----
----
----
Intangible assets
-3.42%18.43M
--18.59M
-3.13%18.76M
--18.9M
-3.23%19.08M
-2.61%19.36M
--19.71M
-3.21%19.88M
-2.64%20.54M
--21.1M
Development expenditure
----
----
----
--0
----
----
----
----
----
----
Long deferred expense
-2.87%1.34M
--1.38M
--1.41M
--1.34M
--1.38M
----
----
----
----
----
Deferred tax assets
82.14%40.81M
--25.92M
40.71%20.82M
--18.21M
79.73%22.41M
161.34%14.8M
--12.47M
136.91%5.66M
15.66%2.39M
--2.07M
Usufruct assets
-26.92%3.41M
--3.75M
-50.60%3.73M
--4.14M
-47.07%4.67M
-25.00%7.56M
--8.82M
--10.08M
----
----
Other non current assets
----
--1.29M
-69.20%1.13M
--5.66M
7.87%3.42M
-94.69%3.65M
--3.17M
2,200.57%68.77M
2,357.11%2.99M
--121.65K
Total non current assets
2.13%321.49M
--306.44M
-4.07%302.54M
--308.81M
2.03%314.77M
4.44%315.38M
--308.52M
124.27%301.98M
48.57%134.65M
--90.63M
Total assets
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
133.79%646.34M
68.14%276.47M
--164.43M
Liabilities
Current liabilities
Notes payable and accounts payable
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
249.58%46.37M
-6.40%13.27M
--14.17M
-Accounts payable
82.01%134.53M
--69.35M
10.67%52.71M
--39.34M
-11.84%73.92M
2.72%47.63M
--83.84M
249.58%46.37M
-6.40%13.27M
--14.17M
Contract liabilities
-18.22%4.51M
--2.63M
32.51%5.97M
--2.92M
83.48%5.52M
7.18%4.5M
--3.01M
22.28%4.2M
--3.44M
----
Advance receipts
----
----
----
----
----
----
----
----
----
--3.61M
Salaries payable
11.25%13.14M
--9.75M
18.18%12.78M
--10.83M
8.97%11.81M
48.13%10.82M
--10.84M
43.70%7.3M
47.65%5.08M
--3.44M
Taxs payable
45.27%43.09M
--20.86M
-33.32%19.26M
--22.12M
-29.67%29.66M
207.70%28.88M
--42.18M
504.16%9.38M
31.62%1.55M
--1.18M
Other payable (including interest and dividends)
10.69%1.28M
--1.11M
7.21%1.6M
--1.28M
-14.64%1.15M
-67.90%1.49M
--1.35M
800.51%4.66M
-82.07%517K
--2.88M
-Dividend payable
----
----
----
----
----
----
----
--3.44M
----
----
-Other payable
10.69%1.28M
----
7.21%1.6M
----
-14.64%1.15M
22.85%1.49M
--1.35M
135.32%1.22M
-82.07%517K
--2.88M
Non current liabilities due within one year
-26.93%1.34M
--1.33M
-22.27%1.95M
--1.9M
-25.45%1.83M
4.75%2.51M
--2.46M
--2.4M
----
----
Other current liabilities
17.00%846.53K
--341.68K
11.09%842.18K
--415.51K
44.71%723.52K
-36.57%758.09K
--499.99K
218.74%1.2M
--374.97K
----
Total current liabilities
59.48%198.74M
--105.36M
-1.53%95.12M
--78.81M
-13.56%124.62M
27.92%96.6M
--144.17M
211.66%75.52M
-4.19%24.23M
--25.29M
Current liabilities
Deferred tax liabilities
-21.02%399.35K
--388.49K
-23.53%435.64K
--460.34K
3,295.05%505.65K
295.46%569.69K
--14.89K
165.87%144.06K
--54.18K
----
Long term deferred income
-54.82%9.94K
--10.58K
-95.87%11.21K
--11.85K
-96.70%22.01K
-75.91%271.51K
--667.83K
-44.91%1.13M
14.89%2.05M
--1.78M
Lease liabilities
-32.75%2.11M
--2.45M
-62.13%2.04M
--2.51M
-53.02%3.13M
-31.80%5.39M
--6.67M
--7.91M
----
----
Other non current liabilities
----
----
----
--0
----
----
----
----
----
----
Total non current liabilities
-31.27%2.52M
--2.84M
-60.08%2.49M
--2.98M
-50.20%3.66M
-32.08%6.23M
--7.35M
337.06%9.18M
17.93%2.1M
--1.78M
Total liabilities
56.89%201.26M
--108.21M
-5.08%97.61M
--81.79M
-15.34%128.28M
21.42%102.83M
--151.52M
221.67%84.69M
-2.74%26.33M
--27.07M
Shareholders equity
Paid-in capital
17.65%404.59M
--404.59M
17.65%404.59M
--343.9M
0.00%343.9M
0.00%343.9M
--343.9M
233.66%343.9M
71.79%103.07M
--60M
Capital reserve funds
876.45%1.01B
--1.01B
888.93%1.01B
--104.16M
1.76%103.94M
0.88%102.59M
--102.14M
-13.29%101.69M
1,659.20%117.28M
--6.67M
Surplus reserve funds
37.41%48.96M
--48.96M
37.41%48.96M
--35.63M
66.95%35.63M
66.95%35.63M
--21.34M
132.15%21.34M
143.25%9.19M
--3.78M
Retained profit
56.81%564.41M
--488.63M
88.45%453.16M
--421.2M
107.75%359.93M
153.90%240.46M
--173.25M
359.78%94.71M
-69.22%20.6M
--66.91M
Shareholders equity without minority interests
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
124.53%561.65M
82.10%250.14M
--137.36M
Total shareholder equity
141.03%2.03B
--1.96B
165.89%1.92B
--904.89M
31.65%843.41M
28.66%722.59M
--640.64M
124.53%561.65M
82.10%250.14M
--137.36M
Total liabilityies and equity
129.93%2.23B
--2.07B
144.59%2.02B
--986.69M
22.66%971.68M
27.71%825.42M
--792.16M
133.79%646.34M
68.14%276.47M
--164.43M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
Unqualified opinion
--
Unqualified opinion
Unqualified opinion
Unqualified opinion
Auditor
--
--
Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)
--
--
Rong Shing Certified Public Accountants (Special General Partnership)
--
Rong Shing Certified Public Accountants (Special General Partnership)
Rong Shing Certified Public Accountants (Special General Partnership)
Rong Shing Certified Public Accountants (Special General Partnership)
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Assets
Current assets
Money funds -36.75%259.18M--104.74M-33.78%243.83M--458.6M60.55%409.79M78.58%368.21M--255.25M421.63%206.19M27.02%39.53M--31.12M
Transactional financial assets 61.76%134.6M--27.64M130.64%19M--93.4M-13.49%83.21M-85.35%8.24M--96.19M33.35%56.24M883.39%42.17M--4.29M
Notes receivable and accounts receivable 563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M-15.59%2.34M-16.65%2.78M--3.33M
-Accounts receivable 563.93%39.58M--12.36M303.46%4.82M--8.44M-19.43%5.96M-49.03%1.19M--7.4M-15.59%2.34M-16.65%2.78M--3.33M
Other receivables (including interest and dividends) 75.46%3.87M--2.46M-61.30%2.3M--3.63M28.15%2.21M326.97%5.94M--1.72M-0.82%1.39M16.52%1.4M--1.2M
-Dividend receivable --------------0------------------------
-Accrued interest receivable --------------0------------------------
-Other receivable 75.46%3.87M-----61.30%2.3M--3.63M28.15%2.21M326.97%5.94M--1.72M-0.82%1.39M16.52%1.4M--1.2M
Advance payment -23.29%9.37M--15.93M8.61%8.31M--11.34M6.69%12.22M-32.80%7.65M--11.45M250.20%11.39M27.25%3.25M--2.56M
Inventories 23.68%166.25M--141.06M-9.54%92.91M--101.02M20.47%134.42M80.52%102.71M--111.58M25.82%56.9M52.90%45.22M--29.58M
Other current assets 14,180.24%1.3B--1.45B8,258.92%1.35B--1.46M15,178.26%9.1M62.39%16.09M--59.58K32.78%9.91M332.19%7.46M--1.73M
Total current assets 191.16%1.91B--1.76B236.51%1.72B--677.88M35.82%656.91M48.12%510.04M--483.64M142.82%344.36M92.16%141.82M--73.8M
Non Current assets
Fixed assets -4.23%249.57M-----3.55%254.86M----31.04%260.6M38.76%264.24M--198.87M283.00%190.43M-8.27%49.72M--54.2M
Fixed assets liquidation ----------------------------------1.67K----
Constru in process 145.88%7.94M-----68.36%1.82M-----95.07%3.23M-19.57%5.76M--65.48M-87.85%7.17M349.03%59.01M--13.14M
Productive biological assets --------------0------------------------
Intangible assets -3.42%18.43M--18.59M-3.13%18.76M--18.9M-3.23%19.08M-2.61%19.36M--19.71M-3.21%19.88M-2.64%20.54M--21.1M
Development expenditure --------------0------------------------
Long deferred expense -2.87%1.34M--1.38M--1.41M--1.34M--1.38M--------------------
Deferred tax assets 82.14%40.81M--25.92M40.71%20.82M--18.21M79.73%22.41M161.34%14.8M--12.47M136.91%5.66M15.66%2.39M--2.07M
Usufruct assets -26.92%3.41M--3.75M-50.60%3.73M--4.14M-47.07%4.67M-25.00%7.56M--8.82M--10.08M--------
Other non current assets ------1.29M-69.20%1.13M--5.66M7.87%3.42M-94.69%3.65M--3.17M2,200.57%68.77M2,357.11%2.99M--121.65K
Total non current assets 2.13%321.49M--306.44M-4.07%302.54M--308.81M2.03%314.77M4.44%315.38M--308.52M124.27%301.98M48.57%134.65M--90.63M
Total assets 129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M133.79%646.34M68.14%276.47M--164.43M
Liabilities
Current liabilities
Notes payable and accounts payable 82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M249.58%46.37M-6.40%13.27M--14.17M
-Accounts payable 82.01%134.53M--69.35M10.67%52.71M--39.34M-11.84%73.92M2.72%47.63M--83.84M249.58%46.37M-6.40%13.27M--14.17M
Contract liabilities -18.22%4.51M--2.63M32.51%5.97M--2.92M83.48%5.52M7.18%4.5M--3.01M22.28%4.2M--3.44M----
Advance receipts --------------------------------------3.61M
Salaries payable 11.25%13.14M--9.75M18.18%12.78M--10.83M8.97%11.81M48.13%10.82M--10.84M43.70%7.3M47.65%5.08M--3.44M
Taxs payable 45.27%43.09M--20.86M-33.32%19.26M--22.12M-29.67%29.66M207.70%28.88M--42.18M504.16%9.38M31.62%1.55M--1.18M
Other payable (including interest and dividends) 10.69%1.28M--1.11M7.21%1.6M--1.28M-14.64%1.15M-67.90%1.49M--1.35M800.51%4.66M-82.07%517K--2.88M
-Dividend payable ------------------------------3.44M--------
-Other payable 10.69%1.28M----7.21%1.6M-----14.64%1.15M22.85%1.49M--1.35M135.32%1.22M-82.07%517K--2.88M
Non current liabilities due within one year -26.93%1.34M--1.33M-22.27%1.95M--1.9M-25.45%1.83M4.75%2.51M--2.46M--2.4M--------
Other current liabilities 17.00%846.53K--341.68K11.09%842.18K--415.51K44.71%723.52K-36.57%758.09K--499.99K218.74%1.2M--374.97K----
Total current liabilities 59.48%198.74M--105.36M-1.53%95.12M--78.81M-13.56%124.62M27.92%96.6M--144.17M211.66%75.52M-4.19%24.23M--25.29M
Current liabilities
Deferred tax liabilities -21.02%399.35K--388.49K-23.53%435.64K--460.34K3,295.05%505.65K295.46%569.69K--14.89K165.87%144.06K--54.18K----
Long term deferred income -54.82%9.94K--10.58K-95.87%11.21K--11.85K-96.70%22.01K-75.91%271.51K--667.83K-44.91%1.13M14.89%2.05M--1.78M
Lease liabilities -32.75%2.11M--2.45M-62.13%2.04M--2.51M-53.02%3.13M-31.80%5.39M--6.67M--7.91M--------
Other non current liabilities --------------0------------------------
Total non current liabilities -31.27%2.52M--2.84M-60.08%2.49M--2.98M-50.20%3.66M-32.08%6.23M--7.35M337.06%9.18M17.93%2.1M--1.78M
Total liabilities 56.89%201.26M--108.21M-5.08%97.61M--81.79M-15.34%128.28M21.42%102.83M--151.52M221.67%84.69M-2.74%26.33M--27.07M
Shareholders equity
Paid-in capital 17.65%404.59M--404.59M17.65%404.59M--343.9M0.00%343.9M0.00%343.9M--343.9M233.66%343.9M71.79%103.07M--60M
Capital reserve funds 876.45%1.01B--1.01B888.93%1.01B--104.16M1.76%103.94M0.88%102.59M--102.14M-13.29%101.69M1,659.20%117.28M--6.67M
Surplus reserve funds 37.41%48.96M--48.96M37.41%48.96M--35.63M66.95%35.63M66.95%35.63M--21.34M132.15%21.34M143.25%9.19M--3.78M
Retained profit 56.81%564.41M--488.63M88.45%453.16M--421.2M107.75%359.93M153.90%240.46M--173.25M359.78%94.71M-69.22%20.6M--66.91M
Shareholders equity without minority interests 141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M124.53%561.65M82.10%250.14M--137.36M
Total shareholder equity 141.03%2.03B--1.96B165.89%1.92B--904.89M31.65%843.41M28.66%722.59M--640.64M124.53%561.65M82.10%250.14M--137.36M
Total liabilityies and equity 129.93%2.23B--2.07B144.59%2.02B--986.69M22.66%971.68M27.71%825.42M--792.16M133.79%646.34M68.14%276.47M--164.43M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion----Unqualified opinion--Unqualified opinionUnqualified opinionUnqualified opinion
Auditor ----Guangdong Sinong Certified Public Accountants Firm (Special General Partnership)----Rong Shing Certified Public Accountants (Special General Partnership)--Rong Shing Certified Public Accountants (Special General Partnership)Rong Shing Certified Public Accountants (Special General Partnership)Rong Shing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg